
Sarissa Capital Management LP is an Activist Hedge Fund based in New York, NY led by Alexander John Denner, reporting $558.6M in AUM as of Q3 2025 with 89% Healthcare concentration, with only 8 positions, and 28% allocation to INVA.
Largest long holdings in Sarissa Capital Management LP's portfolio (100% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Biotechnology Healthcare | $51.4M | 28.49% | — | 4.47% 2.8M shares | |
Drug Manufacturers - Specialty & Generic Healthcare | $42.6M | 23.59% | — | 0.31% 303.2K shares | |
Biotechnology Healthcare | $32.3M | 17.93% | — | 0.49% 588.4K shares | |
Drug Manufacturers - Specialty & Generic Healthcare | $20.9M | 11.56% | — | 9.80% 15.9M shares | |
Unknown Unknown | $20.4M | 11.28% | — | — 1.2M shares | |
Drug Manufacturers - Specialty & Generic Healthcare | $9.3M | 5.16% | +$4.4M Bought | 0.27% 181.5K shares | |
Biotechnology Healthcare | $2.4M | 1.31% | +$2.4M New | 0.00% 4.2K shares | |
Biotechnology Healthcare | $1.2M | 0.69% | -$87.7 Sold | 0.37% 25.4K shares |
Portfolio activity, position movements, and quarter-over-quarter changes in Sarissa Capital Management LP's latest filing
| Position | Shares Δ |
|---|---|
New | |
+88.52% |
| Position | Shares Δ |
|---|---|
-0.01% |
Portfolio insights and performance metrics for Sarissa Capital Management LP
We use cookies for analytics. See our Privacy and Cookie Policy.